$TAC

TransAlta (TAC) Earns Buy Rating From TD Securities Despite Recent Share Weakness

TD Securities resumed coverage of TransAlta (NYSE:TAC) on June 10 with a Buy rating and a C$26 price target after the company completed a bought-deal equity offering. The firm cited a 13% stock pullback tied to concerns about TransAlta’s planned $1B acquisition of two Denver-area gas peakers from Blackstone. The assets total 318 MW, with expected ~$80M annual adjusted core profit and ~$33M free cash flow.

Original reporting
Published Jun 26, 2026, 6:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 6:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TransAlta (TAC) Earns Buy Rating From TD Securities Despite Recent Share Weakness — source image
Decision brief

The 30-second read

$TACBullishLow
01

Why it matters

The new analyst stance may influence short-term positioning, but the article is largely a synthesis of the acquisition and financing already described, with no incremental company guidance or regulatory/earnings datapoint.

02

Market read

Traders may use the Buy/target update as a sentiment input, but the piece does not introduce a fresh earnings/guidance or deal revision beyond the described transaction structure.

03

What to watch

Free-cash-flow and adjusted core profit figures are presented, but the piece doesn’t quantify sensitivity to gas/power spreads, refinancing terms for assumed project debt, or integration/contract performance—key drivers for whether the target is credible.

Relevance 4/10Novelty 4/10Timing: after-hours/early pre-market coverage update (June 26) referencing June 10 initiation and recent equity offering

Background

TD Securities resumed coverage of TransAlta on June 10 with a Buy rating and C$26 target after TransAlta completed a bought-deal equity offering connected to its acquisition of two Colorado gas-fired peaking facilities.

Company-level read

Ticker impact

$TACBullishMedium confidence
Context

TD Securities resumed coverage of TransAlta with a Buy rating and set a C$26 target after the company completed a bought-deal equity offering tied to its Colorado acquisition.

Expected impact

Likely supports downside stabilization and modest upside bias versus the recent pullback, with follow-through dependent on deal execution and Alberta data-center progress.

Evidence & confidence

The article’s actionable catalyst is the TD Securities Buy rating and C$26 target, framed around the acquisition and equity offering; it does not add new deal economics beyond what’s already described.

Market effects

Reinforces investor focus on flexible gas generation and long-duration contracted tolling structures supporting utility/power producer valuations.

Highlights Western US power-market expansion and near-term Alberta data-center opportunity as key demand drivers.

Limited global spillover; primarily North American power and infrastructure capital allocation narrative.

Counterpoint

The article emphasizes the stock’s 13% pullback due to concerns about asset characteristics and valuation—suggesting the market may already be discounting execution/valuation risk despite the Buy call.

Key entities

  • TransAlta Corporation

    Subject of the article; received TD Securities Buy rating and C$26 price target after completing a bought-deal equity offering tied to a Colorado peaking-assets acquisition.

  • TD Securities

    Resumed coverage with Buy rating and set C$26 price target; cited acquisition strategy fit and near-term Alberta data center progress.

  • Blackstone

    Seller of the two Colorado peaking facilities (per Reuters report cited in the article).

Related articles

$TACMedAI 8/10

Canadian Energy News, Top Headlines, Commentaries, Features & Events

TransAlta Corp said it will buy two natural gas peaking plants near Denver, Mountain Peak Power and Canyon Peak Power, from Blackstone for about $1 billion. The 318 MW assets are fully contracted for over 25 years. TransAlta will assume $750 million project debt and raise about $250 million equity via a C$350 million bought deal. Expected annual adjusted core profit is ~$80 million and free cash flow ~$33 million; deal closes early Q4 2026.

$TACMed

Across the Nutraverse: Probiotic foods in China, Akkermansia I.P., IM8’s $1bn financing deal

SAMR has drafted new China rules for probiotic health foods, open for consultation until Aug 24, 2026, including higher minimum CFU at shelf life and required strain details for traceability and quality. The Akkermansia Company received a new US patent covering marketing substantially purified Akkermansia for metabolic disorders, including live and pasteurized forms. IM8 secured $1bn growth financing from General Catalyst’s CVF to expand internationally.

$TACMed

The tab to keep a Northwest coal plant on standby keeps rising. Who will pay?

Utilities in the Pacific Northwest are contesting TransAlta’s request to recover costs for keeping its Centralia, Washington coal plant on standby under renewed Trump-era DOE emergency orders. TransAlta says its first April 30 invoice was nearly $20 million and estimates $23 million for repairs if standby extends into Q3–Q4 2026. FERC is reviewing opposition from utilities and grid operators.

$TACMedAI 8/10

TransAlta (NYSE:TAC) Stock Price Passes Above 200

TransAlta (NYSE:TAC) shares rose above their 200-day moving average on Monday, trading up to $13.82 and last at $13.5650. The 200-day average is $13.23. The article cites analyst actions including RBC and CIBC reiterating “outperform” and TD Securities “buy,” with MarketBeat showing a $21.33 consensus target. It also notes May 6 quarterly EPS of $0.04 vs $0.01 expected and a $0.07 quarterly dividend payable July 1.